Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2026-04-11 @ 7:55 AM
Study NCT ID:
NCT06888492
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-03-21
First Post:
2025-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)
Sponsor:
Hangzhou Jiayin Biotech Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EXG202-011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None